JPY 2388.0
(0.55%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 7.6 Billion JPY | 64.62% |
2022 | 4.61 Billion JPY | -2.68% |
2021 | 4.74 Billion JPY | -22.53% |
2020 | 6.12 Billion JPY | -21.75% |
2019 | 7.82 Billion JPY | -30.57% |
2018 | 11.27 Billion JPY | 5.12% |
2017 | 10.72 Billion JPY | -27.42% |
2016 | 14.77 Billion JPY | -1.44% |
2015 | 14.99 Billion JPY | 108.51% |
2014 | 7.19 Billion JPY | 81.61% |
2013 | 3.95 Billion JPY | -3.37% |
2012 | 4.09 Billion JPY | -55.54% |
2011 | 9.21 Billion JPY | 12.76% |
2010 | 8.17 Billion JPY | -37.66% |
2009 | 13.1 Billion JPY | -2.29% |
2008 | 13.41 Billion JPY | 20.47% |
2007 | 11.13 Billion JPY | -7.99% |
2006 | 12.1 Billion JPY | -3.75% |
2005 | 12.57 Billion JPY | -0.3% |
2004 | 12.61 Billion JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 8.83 Billion JPY | 16.15% |
2023 Q4 | 7.6 Billion JPY | 0.04% |
2023 Q3 | 7.59 Billion JPY | 23.36% |
2023 FY | 7.6 Billion JPY | 64.62% |
2023 Q2 | 6.16 Billion JPY | 53.96% |
2023 Q1 | 4 Billion JPY | -13.36% |
2022 Q1 | 3.39 Billion JPY | -28.45% |
2022 Q4 | 4.61 Billion JPY | 4.43% |
2022 FY | 4.61 Billion JPY | -2.68% |
2022 Q3 | 4.42 Billion JPY | 19.74% |
2022 Q2 | 3.69 Billion JPY | 8.78% |
2021 Q3 | 5.22 Billion JPY | 11.25% |
2021 Q1 | 5.76 Billion JPY | -5.81% |
2021 Q2 | 4.69 Billion JPY | -18.67% |
2021 Q4 | 4.74 Billion JPY | -9.1% |
2021 FY | 4.74 Billion JPY | -22.53% |
2020 Q1 | 7.17 Billion JPY | -8.3% |
2020 Q4 | 6.12 Billion JPY | -3.86% |
2020 FY | 6.12 Billion JPY | -21.75% |
2020 Q3 | 6.37 Billion JPY | -3.04% |
2020 Q2 | 6.57 Billion JPY | -8.44% |
2019 Q4 | 7.82 Billion JPY | 0.73% |
2019 FY | 7.82 Billion JPY | -30.57% |
2019 Q1 | 10.06 Billion JPY | -10.71% |
2019 Q3 | 7.77 Billion JPY | -12.07% |
2019 Q2 | 8.83 Billion JPY | -12.21% |
2018 FY | 11.27 Billion JPY | 5.12% |
2018 Q1 | 9.34 Billion JPY | -12.83% |
2018 Q2 | 9.15 Billion JPY | -2.04% |
2018 Q3 | 10.52 Billion JPY | 14.87% |
2018 Q4 | 11.27 Billion JPY | 7.17% |
2017 FY | 10.72 Billion JPY | -27.42% |
2017 Q4 | 10.72 Billion JPY | 3.56% |
2017 Q3 | 10.35 Billion JPY | -0.56% |
2017 Q2 | 10.41 Billion JPY | 10.82% |
2017 Q1 | 9.39 Billion JPY | -36.4% |
2016 Q3 | 9.64 Billion JPY | 6.48% |
2016 Q1 | 9.18 Billion JPY | -38.76% |
2016 Q2 | 9.06 Billion JPY | -1.32% |
2016 FY | 14.77 Billion JPY | -1.44% |
2016 Q4 | 14.77 Billion JPY | 53.17% |
2015 Q2 | 6.38 Billion JPY | 0.61% |
2015 Q3 | 8.57 Billion JPY | 34.32% |
2015 Q4 | 14.99 Billion JPY | 74.92% |
2015 Q1 | 6.34 Billion JPY | -11.79% |
2015 FY | 14.99 Billion JPY | 108.51% |
2014 Q2 | 2.55 Billion JPY | 40.25% |
2014 Q3 | 4.52 Billion JPY | 77.06% |
2014 FY | 7.19 Billion JPY | 81.61% |
2014 Q1 | 1.82 Billion JPY | -54.0% |
2014 Q4 | 7.19 Billion JPY | 59.0% |
2013 FY | 3.95 Billion JPY | -3.37% |
2013 Q4 | 3.95 Billion JPY | 11.05% |
2013 Q1 | 4.23 Billion JPY | 3.39% |
2013 Q2 | 3.46 Billion JPY | -18.18% |
2013 Q3 | 3.56 Billion JPY | 2.86% |
2012 Q3 | 4.15 Billion JPY | -55.57% |
2012 Q4 | 4.09 Billion JPY | -1.35% |
2012 Q2 | 9.34 Billion JPY | 11.75% |
2012 Q1 | 8.36 Billion JPY | -9.22% |
2012 FY | 4.09 Billion JPY | -55.54% |
2011 Q3 | 8.31 Billion JPY | 15.99% |
2011 FY | 9.21 Billion JPY | 12.76% |
2011 Q1 | 7.93 Billion JPY | -2.9% |
2011 Q2 | 7.16 Billion JPY | -9.68% |
2011 Q4 | 9.21 Billion JPY | 10.85% |
2010 Q3 | 9.23 Billion JPY | -16.21% |
2010 Q1 | 12 Billion JPY | -8.41% |
2010 FY | 8.17 Billion JPY | -37.66% |
2010 Q4 | 8.17 Billion JPY | -11.52% |
2010 Q2 | 11.02 Billion JPY | -8.2% |
2009 Q3 | 14.87 Billion JPY | 14.3% |
2009 Q4 | 13.1 Billion JPY | -11.86% |
2009 Q2 | 13.01 Billion JPY | 0.0% |
2009 FY | 13.1 Billion JPY | -2.29% |
2008 Q4 | 13.41 Billion JPY | 5.24% |
2008 FY | 13.41 Billion JPY | 20.47% |
2008 Q3 | 12.74 Billion JPY | 0.0% |
2007 FY | 11.13 Billion JPY | -7.99% |
2006 FY | 12.1 Billion JPY | -3.75% |
2005 FY | 12.57 Billion JPY | -0.3% |
2004 FY | 12.61 Billion JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -520.571% |
Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.827% |
Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 98.05% |
Shionogi & Co., Ltd. | -346.47 Billion JPY | 102.194% |
Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 313.293% |
Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 118.033% |
Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 112.366% |
Eisai Co., Ltd. | -97.93 Billion JPY | 107.763% |
Morishita Jintan Co., Ltd. | -667 Million JPY | 1239.73% |
Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 114.67% |
Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 123.092% |
Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 2.3% |
Tsumura & Co. | 1.61 Billion JPY | -370.712% |
Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 117.215% |
Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 122.075% |
Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 95.598% |
Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 71.447% |
Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 73.77% |
KYORIN Holdings, Inc. | 7.06 Billion JPY | -7.677% |
Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -979.83% |
Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -26.869% |
SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 216.649% |
MedRx Co., Ltd | -1.72 Billion JPY | 541.977% |
Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 187.214% |
Solasia Pharma K.K. | -668 Million JPY | 1238.024% |
Modalis Therapeutics Corporation | -1.47 Billion JPY | 616.813% |
ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 204.812% |
Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 86.55% |
Cyfuse Biomedical K.K. | -2.96 Billion JPY | 356.757% |
Toho Holdings Co., Ltd. | -98.42 Billion JPY | 107.723% |
Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 168.304% |